Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD

[1]  A. Lundervold,et al.  Association between Catechol O‐methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in Adults , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  M Hoogman,et al.  Association of the dopamine transporter (SLC6A3/DAT1) gene 9–6 haplotype with adult ADHD , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  B. Franke,et al.  Association of ADHD with genetic variants in the 5′‐region of the dopamine transporter gene: Evidence for allelic heterogeneity , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  B. Franke,et al.  Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  Aribert Rothenberger,et al.  Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  B. Kolachana,et al.  Epistasis between Dopamine Regulating Genes Identifies a Nonlinear Response of the Human Hippocampus During Memory Tasks , 2008, Biological Psychiatry.

[7]  J Ormel,et al.  The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative , 2008, Occupational and Environmental Medicine.

[8]  J. Buitelaar,et al.  A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.

[9]  J. Persson,et al.  ADHD from a socio‐economic perspective , 2008, Acta paediatrica.

[10]  Philip Asherson,et al.  Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post‐mortem midbrain tissue , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  D. Goodman.  The Consequences of Attention-Deficit/Hyperactivity Disorder in Adults , 2007, Journal of psychiatric practice.

[12]  A. Diamond.  Consequences of variations in genes that affect dopamine in prefrontal cortex. , 2007, Cerebral cortex.

[13]  Pak Sham,et al.  A meta‐analysis of association studies between the 10‐repeat allele of a VNTR polymorphism in the 3′‐UTR of dopamine transporter gene and attention deficit hyperactivity disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[15]  J. Gläscher,et al.  Gene–gene interaction associated with neural reward sensitivity , 2007, Proceedings of the National Academy of Sciences.

[16]  B. Franke,et al.  Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. , 2007, The American journal of psychiatry.

[17]  A. Georgi,et al.  No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3′UTR of the DAT1 gene and adult attention deficit hyperactivity disorder , 2007, Psychiatric genetics.

[18]  J. Shih,et al.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults , 2007, Human Genetics.

[19]  Lin He,et al.  Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). , 2006, Human molecular genetics.

[20]  Bradford Navia,et al.  An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[22]  R. Murray,et al.  A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Barkley,et al.  Young adult outcome of hyperactive children: adaptive functioning in major life activities. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  Gerome Breen,et al.  A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. , 2006, Archives of general psychiatry.

[25]  S. Nelson,et al.  Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. , 2005, Journal of Child Psychology and Psychiatry and Allied Disciplines.

[26]  J. Smoller,et al.  Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[27]  Ali A. Bonab,et al.  In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter , 2005, Biological Psychiatry.

[28]  T. B. Üstün,et al.  Patterns and Predictors of Attention-Deficit/Hyperactivity Disorder Persistence into Adulthood: Results from the National Comorbidity Survey Replication , 2005, Biological Psychiatry.

[29]  B. Madras,et al.  The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[30]  Joseph Biederman,et al.  The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.

[31]  Jan K Buitelaar,et al.  Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults , 2004, Psychological Medicine.

[32]  Elias Zintzaras,et al.  Association of paraoxonase 1 gene polymorphisms with risk of Parkinson′s disease: a meta-analysis , 2004, Journal of Human Genetics.

[33]  E. Sobanski,et al.  [Attention deficit hyperactivity disorder in adults. An overview]. , 2004, Der Nervenarzt.

[34]  S. Faraone.  Genetics of adult attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.

[35]  S. Faraone,et al.  Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder , 2004, Journal of clinical psychopharmacology.

[36]  A. Whitehead.  Dealing with Heterogeneity , 2003 .

[37]  S. Faraone.  Report from the 4th International Meeting of the Attention Deficit Hyperactivity Disorder Molecular Genetics Network , 2001, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[38]  Mary L Marazita,et al.  Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis , 2002, Psychiatric genetics.

[39]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[40]  S. Faraone.  Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. , 2002, American journal of medical genetics.

[41]  S. Faraone,et al.  Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. , 2000, The American journal of psychiatry.

[42]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[43]  François Rousset,et al.  GENEPOP (version 1.2): population genetic software for exact tests and ecumenicism , 1995 .

[44]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[45]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[46]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[47]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.